Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Federico Martinón-Torres, Isabelle Bertrand-Gerentes & Philipp Oster. (2021) A novel vaccine to prevent meningococcal disease beyond the first year of life: an early review of MenACYW-TT. Expert Review of Vaccines 20:9, pages 1123-1146.
Read now
Read now
Judith Kirstein, Miriam Pina, Judy Pan, Emilia Jordanov & Mandeep S. Dhingra. (2020) Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adults 56 years of age and older: a Phase II randomized study. Human Vaccines & Immunotherapeutics 16:6, pages 1299-1305.
Read now
Read now
Federico Martinón-Torres, Terry Nolan, Daniela Toneatto & Angelika Banzhoff. (2019) Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults. Human Vaccines & Immunotherapeutics 15:12, pages 2940-2951.
Read now
Read now
Justine Alderfer, Amit Srivastava, Raul Isturiz, Cynthia Burman, Judith Absalon, Johannes Beeslaar & John Perez. (2019) Concomitant administration of meningococcal vaccines with other vaccines in adolescents and adults: a review of available evidence. Human Vaccines & Immunotherapeutics 15:9, pages 2205-2216.
Read now
Read now
Robert Booy, Angela Gentile, Michael Nissen, Jane Whelan & Véronique Abitbol. (2019) Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies. Human Vaccines & Immunotherapeutics 15:2, pages 470-480.
Read now
Read now
Pavitra Keshavan, Michele Pellegrini, Kumaran Vadivelu-Pechai & Michael Nissen. (2018) An update of clinical experience with the quadrivalent meningococcal ACWY-CRM conjugate vaccine. Expert Review of Vaccines 17:10, pages 865-880.
Read now
Read now
A. W. Dretler, N. G. Rouphael & D. S. Stephens. (2018) Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development. Human Vaccines & Immunotherapeutics 14:5, pages 1146-1160.
Read now
Read now
Daniela Toneatto, Mariagrazia Pizza, Vega Masignani & Rino Rappuoli. (2017) Emerging experience with meningococcal serogroup B protein vaccines. Expert Review of Vaccines 16:5, pages 433-451.
Read now
Read now
Ray Borrow, Pedro Alarcón, Josefina Carlos, Dominique A. Caugant, Hannah Christensen, Roberto Debbag, Philippe De Wals, Gabriela Echániz-Aviles, Jamie Findlow, Chris Head, Daphne Holt, Hajime Kamiya, Samir K Saha, Sergey Sidorenko, Muhamed-Kheir Taha, Caroline Trotter, Julio A. Vázquez Moreno, Anne von Gottberg & Marco A. P. Sáfadi. (2017) The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection. Expert Review of Vaccines 16:4, pages 313-328.
Read now
Read now
Ashesh Gandhi, Paul Balmer & Laura J. York. (2016) Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®). Postgraduate Medicine 128:6, pages 548-556.
Read now
Read now
Beatriz P. Quiambao, Hermant Jain, Ashish Bavdekar, Anand Prakash Dubey, Devayani Kolhe, Véronique Bianco, Marie Van der Wielen & Jacqueline M. Miller. (2016) Persistence of the immune response two years after vaccination with quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in Asian adolescents. Human Vaccines & Immunotherapeutics 12:8, pages 2162-2168.
Read now
Read now
Volker Vetter, Roger Baxter, Gülhan Denizer, Marco A. P. Sáfadi, Sven-Arne Silfverdal, Andrew Vyse & Ray Borrow. (2016) Routinely vaccinating adolescents against meningococcus: targeting transmission & disease. Expert Review of Vaccines 15:5, pages 641-658.
Read now
Read now
Elena Gianchecchi, Alessandro Torelli, Giulia Piccini, Simona Piccirella & Emanuele Montomoli. (2015) Neisseria meningitidis infection: who, when and where?. Expert Review of Anti-infective Therapy 13:10, pages 1249-1263.
Read now
Read now
Mairi Vella & David Pace. (2015) Glycoconjugate vaccines: an update. Expert Opinion on Biological Therapy 15:4, pages 529-546.
Read now
Read now
Andrew Vyse, Andrea Anonychuk, Anne Jäkel, Heather Wieffer & Simon Nadel. (2013) The burden and impact of severe and long-term sequelae of meningococcal disease. Expert Review of Anti-infective Therapy 11:6, pages 597-604.
Read now
Read now
Articles from other publishers (31)
Noa Sofer-Sali, Diana Roif-Kaminsky, Yair Motro, Boris Khalfin, Eva Avramovich, Inbal Galor, Amir Shlaifer, Adir Sommer, Ran Rutenberg, Yacov Sachter, Avraham Yitzhak, Daniel Grupel & Jacob Moran-Gilad. (2022)
Prevalence and Characteristics of Carriage of
Neisseria meningitidis
Among Young Israeli Adults
. Open Forum Infectious Diseases 9:10.
Crossref
Crossref
Sandra Guedes, Isabelle Bertrand-Gerentes, Keith Evans, Florence Coste & Philipp Oster. (2022) Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature. BMC Public Health 22:1.
Crossref
Crossref
Vasilica Ungureanu. (2022) Essential things to know about meningococcal disease and its prevention. Medic.ro 1:145, pages 22.
Crossref
Crossref
Yih-Ling Tzeng & David S. Stephens. (2021) A Narrative Review of the W, X, Y, E, and NG of Meningococcal Disease: Emerging Capsular Groups, Pathotypes, and Global Control. Microorganisms 9:3, pages 519.
Crossref
Crossref
Heun Choi, Hyuk Min Lee, Woonji Lee, Jun Hyoung Kim, Hye Seong, Jung Ho Kim, Jin Young Ahn, Su Jin Jeong, Nam Su Ku, Joon-Sup Yeom, Kyungwon Lee, Hee Soo Kim, Philipp Oster & Jun Yong Choi. (2021) Longitudinal study of meningococcal carriage rates in university entrants living in a dormitory in South Korea. PLOS ONE 16:1, pages e0244716.
Crossref
Crossref
Khadija Ait Mouss, Aziza Razki, Eva Hong, Bahija Zaki, Fakhreddine Maaloum, Néhémie Nzoyikorera, Houria Belabbes, Naima Elmdaghri & Khalid Zerouali. (2020) Epidemiological profile of Neisseria meningitidis in Casablanca, Morocco: 2010–2019. Access Microbiology 2:9.
Crossref
Crossref
Nabila Monalisa Mendes Dantas Sales, Jailton Azevedo, Marcelo Teles Bastos Ribeiro, Humberto Fonseca de Freitas, Hermes Pedreira da Silva Filho, Soraia Machado Cordeiro, Mitermayer Galvão Reis & Joice Neves Reis. (2020) Long-term impacts of MenC vaccination campaign in the Salvador, Brazil metropolitan region: A comparison of pre- and post-vaccine periods. Vaccine 38:40, pages 6267-6273.
Crossref
Crossref
Alejandra Esteves-Jaramillo, Timothy Koehler, Robert Jeanfreau, David Neveu, Emilia Jordanov & Mandeep Singh Dhingra. (2020) Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in ≥56-year-olds: A Phase III randomized study. Vaccine 38:28, pages 4405-4411.
Crossref
Crossref
Joseph P. Fava, Brittany Stewart, Kathryn M. Dudzinski, Michelle Baker & Lucio Volino. (2018) Emerging Topics in Vaccine Therapeutics for Adolescents and Adults: An Update for Immunizing Pharmacists. Journal of Pharmacy Practice 33:2, pages 192-205.
Crossref
Crossref
Vasilica Ungureanu. (2020) Invasive meningococcal disease – its importance in human pathology and its prevention. Medic.ro 2:134, pages 38.
Crossref
Crossref
Maria Cecília Gorla, Angela Pires Brandao, Juliana Maira Watanabe Pinhata, Camile de Moraes, Gabriela Pereira & Ana Paula Lemos. (2020) Phenotypic characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease in Brazil from 2002 to 2017. Access Microbiology 2:1.
Crossref
Crossref
Elizabeth Packnett, Debra E. Irwin, Patricia Novy, Philip S. Watson, Jane Whelan, Laura Moore-Schiltz, Matthew Lucci & Cosmina Hogea. (2019) Meningococcal-group B (MenB) vaccine series completion and adherence to dosing schedule in the United States: A retrospective analysis by vaccine and payer type. Vaccine 37:39, pages 5899-5908.
Crossref
Crossref
Bing Wang, Renee Santoreneos, Lynne Giles, Hossein Haji Ali Afzali & Helen Marshall. (2019) Case fatality rates of invasive meningococcal disease by serogroup and age: A systematic review and meta-analysis. Vaccine 37:21, pages 2768-2782.
Crossref
Crossref
Enrique Chacon-Cruz, Christopher Roberts, Rosa Maria Rivas-Landeros, Erika Zoe Lopatynsky-Reyes, Lucila Alejandra Almada-Salazar & Jorge Arturo Alvelais-Palacios. (2019)
Pediatric meningitis due to
Neisseria meningitidis, Streptococcus pneumoniae
and Group B Streptococcus in Tijuana, Mexico: active/prospective surveillance, 2005–2018
. Therapeutic Advances in Infectious Disease 6, pages 204993611983227.
Crossref
Crossref
Alessia Liguori, Lucia Dello Iacono, Giulietta Maruggi, Barbara Benucci, Marcello Merola, Paola Lo Surdo, Jacinto López-Sagaseta, Mariagrazia Pizza, Enrico Malito & Matthew J. Bottomley. (2018) NadA3 Structures Reveal Undecad Coiled Coils and LOX1 Binding Regions Competed by Meningococcus B Vaccine-Elicited Human Antibodies. mBio 9:5.
Crossref
Crossref
Mercedes Macias Parra, Angela Gentile, Jorge Alejandro Vazquez Narvaez, Alejandro Capdevila, Angel Minguez, Monica Carrascal, Arnold Willemsen, Chiranjiwi Bhusal & Daniela Toneatto. (2018) Immunogenicity and safety of the 4CMenB and MenACWY-CRM meningococcal vaccines administered concomitantly in infants: A phase 3b, randomized controlled trial. Vaccine 36:50, pages 7609-7617.
Crossref
Crossref
Saber Yezli. (2018) The threat of meningococcal disease during the Hajj and Umrah mass gatherings: A comprehensive review. Travel Medicine and Infectious Disease 24, pages 51-58.
Crossref
Crossref
Lucia Helena De Oliveira, Barbara JaureguiAna Flavia CarvalhoNorberto Giglio. (2017) Impact and effectiveness of meningococcal vaccines: a review. Revista Panamericana de Salud Pública 41, pages 1.
Crossref
Crossref
Muhamed-Kheir Taha, Julio Cesar Hawkins, Paul Liberator, Ala-Eddine Deghmane, Lubomira Andrew, Li Hao, Thomas R. Jones, Lisa K. McNeil, Robert E. O’Neill, John L. Perez, Kathrin U. Jansen & Annaliesa S. Anderson. (2017) Bactericidal activity of sera from adolescents vaccinated with bivalent rLP2086 against meningococcal serogroup B outbreak strains from France. Vaccine 35:11, pages 1530-1537.
Crossref
Crossref
Angelika Banzhoff. (2017) Multicomponent meningococcal B vaccination (4CMenB) of adolescents and college students in the United States. Therapeutic Advances in Vaccines 5:1, pages 3-14.
Crossref
Crossref
Stephen I. Pelton. (2016) The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines. Journal of Adolescent Health 59:2, pages S3-S11.
Crossref
Crossref
Carol J. Baker. (2016) Prevention of Meningococcal Infection in the United States: Current Recommendations and Future Considerations. Journal of Adolescent Health 59:2, pages S29-S37.
Crossref
Crossref
Bruce Atkinson, Ashesh Gandhi & Paul Balmer. (2016) History of Meningococcal Outbreaks in the United States: Implications for Vaccination and Disease Prevention. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36:8, pages 880-892.
Crossref
Crossref
Christos Hadjichristodoulou, George Mpalaouras, Vasiliki Vasilopoulou, Antonios Katsioulis, George Rachiotis, Kalliopi Theodoridou, Georgia Tzanakaki, Vassiliki Syriopoulou & Maria Theodoridou. (2016) A Case-Control Study on the Risk Factors for Meningococcal Disease among Children in Greece. PLOS ONE 11:6, pages e0158524.
Crossref
Crossref
Nicola P. Klein, Yaela Baine, Devayani Kolhe, Carmen I. Baccarini, Jacqueline M. Miller & Marie Van der Wielen. (2016) Five-year Antibody Persistence and Booster Response After 1 or 2 Doses of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Healthy Children. The Pediatric Infectious Disease Journal 35:6, pages 662-672.
Crossref
Crossref
Neil J. Oldfield, Odile B. Harrison, Christopher D. Bayliss, Martin C. J. Maiden, Dlawer A. A. Ala'Aldeen & David P. J. Turner. (2016)
Genomic Analysis of Serogroup Y
Neisseria meningitidis
Isolates Reveals Extensive Similarities Between Carriage-Associated and Disease-Associated Organisms
. Journal of Infectious Diseases 213:11, pages 1777-1785.
Crossref
Crossref
Enrique Chacon-Cruz, Cesar Adrian Martinez-Longoria, Eduardo Llausas-Magana, Antonio Luevanos-Velazquez, Jorge Alejandro Vazquez-Narvaez, Sandra Beltran, Ana Elena Limon-Rojas, Fernando Urtiz-Jeronimo, Jose Luis Castaneda-Narvaez, Francisco Otero-Mendoza, Fernando Aguilar-Del Real, Jesus Rodriguez-Chagoyan, Rosa Maria Rivas-Landeros, Maria Luisa Volker-Soberanes, Rosa Maria Hinojosa-Robles, Patricia Arzate-Barbosa, Laura Karina Aviles-Benitez, Fernando Ivan Elenes-Zamora, Chandra M. Becka & Ricardo Ruttimann. (2016)
Neisseria meningitidis
and
Streptococcus pneumoniae
as leading causes of pediatric bacterial meningitis in nine Mexican hospitals following 3 years of active surveillance
. Therapeutic Advances in Vaccines 4:1-2, pages 15-19.
Crossref
Crossref
E. David McIntosh, Victor Carey, Daniela Toneatto, Peter Dull & James Wassil. (2014) Prevention of rare diseases: how revolutionary techniques can help vulnerable individuals—the example of serogroup B meningococcal infection. Therapeutic Advances in Vaccines 3:1, pages 13-23.
Crossref
Crossref
Domenico Martinelli, Francesca Fortunato, Maria Giovanna Cappelli, Vanessa Cozza, Maria Chironna & Rosa Prato. (2015) Estimation of the Impact of Meningococcal Serogroup C Universal Vaccination in Italy and Suggestions for the Multicomponent Serogroup B Vaccine Introduction. Journal of Immunology Research 2015, pages 1-9.
Crossref
Crossref
Enrique Chacon-Cruz, Luz Elena Espinosa-De Los Monteros, Samuel Navarro-Alvarez, Jose Luis Aranda-Lozano, Maria Luisa Volker-Soberanes, Rosa Maria Rivas-Landeros, Ariadna Annete Alvelais-Arzamendi & Julio Alberto Vazquez. (2014) An outbreak of serogroup C (ST-11) meningococcal disease in Tijuana, Mexico. Therapeutic Advances in Vaccines 2:3, pages 71-76.
Crossref
Crossref
Ying Kong, Jennifer H. Ma, Keisha Warren, Raymond S.W. Tsang, Donald E. Low, Frances B. Jamieson, David C. Alexander & Weilong Hao. (2013) Homologous Recombination Drives Both Sequence Diversity and Gene Content Variation in Neisseria meningitidis. Genome Biology and Evolution 5:9, pages 1611-1627.
Crossref
Crossref